Erratum: Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing (Oncogene (2014) 33 (4786-4794) DOI: 10.1038/onc.2013.424);Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing

Oncogene

Volumn 33, Issue 39, 2014, Pages 4786-4794

  Lin, K T ^a   Shann, Y J ^a   Chau, G Y ^b   Hsu, C N ^c,d,e   Huang, C Y F ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Alternative splicing; DUNQU1; FGFR2; Hepatocellular carcinoma; RNA Seq

Indexed keywords

TRANSCRIPTOME; TUMOR MARKER; FGFR2 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; ISOPROTEIN;

ADULT; AGAR MEDIUM; ALG1L GENE; ALTERNATIVE RNA SPLICING; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DUNQU1 GENE; FEMALE; FETUS; FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC CODE; GENETIC CORRELATION; HEPATITIS B; HEPATITIS C; HEPATOCELLULAR CARCINOMA CELL LINE; HUH7 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; RNA SEQUENCE; SERPINA11 GENE; TISSUE SPECIFICITY; TMEM82 GENE; TRANSCRIPTOMICS; TUMOR GENE; ANTIBODY SPECIFICITY; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; LIVER; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ALTERNATIVE SPLICING; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER; LIVER NEOPLASMS; MALE; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84921731428     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.62     Document Type: Erratum

References (44)

1. Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 2011;12:87-98.
2. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, Scherf M et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008;321:956-960.
3. Morin R, Bainbridge M, Fejes A, Hirst M, Krzywinski M, Pugh T et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively short-read sequencing. Biotechniques 2008;45:81-94.
4. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187-197.
5. Clark MB, Amaral PP, Schlesinger FJ, Dinger ME, Taft RJ, Rinn JL et al. The reality of pervasive transcription. PLoS Biol 2011;9:e1000625, discussion e1001102.
6. Pickrell JK, Pai AA, Gilad Y, Pritchard JK. Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet 2010;6:e1001236.
7. Garber M, Grabherr MG, Guttman M, Trapnell C. Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 2011;8:469-477.
8. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF et al. NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res 2011;39:D1005-D1010.
9. Kapushesky M, Adamusiak T, Burdett T, Culhane A, Farne A, Filippov A et al. Gene Expression Atlas update-a value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res 2012;40:D1077-D1081.
10. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, Dylag M et al. ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res 2011;39:D1002-D1004.
11. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles. Neoplasia 2007;9:166-180.
12. Petretti T, Kemmner W, Schulze B, Schlag PM. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 2000;46:359-366.
13. Parris TZ, Danielsson A, Nemes S, Kovács A, Delle U, Fallenius G et al. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin Cancer Res 2010;16:3860-3874.
14. Zdobnov EM, Apweiler R. InterProScan-an integration platform for the signaturerecognition methods in InterPro. Bioinformatics 2001;17:847-848.
15. Hertervig E, Nilsson A, Nyberg L, Duan RD. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 1997;79:448-453.
16. Cheng Y, Wu J, Hertervig E, Lindgren S, Duan D, Nilsson A et al. Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis. Br J Cancer 2007;97:1441-1448.
17. Eichler EE, Zimmerman AW. A hot spot of genetic instability in autism. N Engl J Med 2008;358:737-739.
18. Bochukova EG, Huang N, Keogh J, Henning E, Purmann C, Blaszczyk K et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010;463:666-670.
19. Myers RM, Stamatoyannopoulos J, Snyder M, Dunham I, Hardison RC, Bernstein BE et al. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011;9:e1001046.
20. Wu J, Akerman M, Sun S, McCombie WR, Krainer AR, Zhang MQ. SpliceTrap: a method to quantify alternative splicing under single cellular conditions. Bioinformatics 2011;27:3010-3016.
21. Kamburov A, Pentchev K, Galicka H, Wierling C, Lehrach H, Herwig R. ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res 2011;39:D712-D717.
22. Takai H, Wang RC, Takai KK, Yang H, De Lange T. Tel2 regulates the stability of PI3K-related protein kinases. Cell 2007;131:1248-1259.
23. Grosso AR, Martins S, Carmo-Fonseca M. The emerging role of splicing factors in cancer. EMBO Rep 2008;9:1087-1093.
24. David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2010;24:2343-2364.
25. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 2009;33:591-601.
26. Amann T, Bataille F, Spruss T, Dettmer K, Wild P, Liedtke C et al. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. Am J Pathol 2010;176:1433-1442.
27. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 2011;7:e1002218.
28. Kleino I, Ortiz RM, Huovila AP. ADAM15 gene structure and differential alternative exon use in human tissues. BMC Mol Biol 2007;8:90.
29. Ortiz RM, Karkkainen I, Huovila AP. Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells. Genes Chromosomes Cancer 2004;41:366-378.
30. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007;98:621-628.
31. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007;26:851-858.
32. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007;132:330-342.
33. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-719.
34. Ecker JR, Bickmore WA, Barroso I, Pritchard JK, Gilad Y, Segal E. Genomics: ENCODE explained. Nature 2012;489:52-55.
35. Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011;478:123-126.
36. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010;10:116-129.
37. Huijts PE, Van Dongen M, De Goeij MC, Van Moolenbroek AJ, Blanken F, Vreeswijk MP et al. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. Breast cancer research: BCR 2011;13:R72.
38. Somarelli JA, Schaeffer D, Bosma R, Bonano VI, Sohn JW, Kemeny G et al. Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo. Rna 2013;19:116-127.
39. Huang Q, Lin B, Liu H, Ma X, Mo F, Yu W et al. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS One 2011;6:e26168.
40. Toung JM, Morley M, Li M, Cheung VG. RNA-sequence analysis of human B-cells. Genome Res 2011;21:991-998.
41. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009;25:1105-1111.
42. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, Savich GL et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res 2010;38:e178.
43. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, Van Baren MJ et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010;28:511-515.
44. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Chen Y et al. Ensembl 2011. Nucleic Acids Res 2011;39:D800-D806.